LTRN

LANTERN PHARMA INC

LTRN·51654W101·US·Common Stock·Healthcare - Biotechnology-Activist

LTRN (LANTERN PHARMA INC) is held by 25 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($454,948), RENAISSANCE TECHNOLOGIES LLC ($158,920), GEODE CAPITAL MANAGEMENT, LLC ($152,984). Net institutional sentiment: Mixed.

25
Holders
Avg rating(5 Elite)
$1.2M
Total Value
48% (28)
Fund Consensus
10 buying - 11 selling
LTRNSmart Money Verdict
View all
Held by 25 funds
5 elite
Who's Trading
ActivistBABIOS ADVISORS GP, LLC4.5%May 15, 2026
InsiderSTSchalop Lee TroyBuy $100KMay 12, 2026
ActivistBEBios Equity Partners, LP3.7%Apr 16, 2026
ActivistTAThomas A. Satterfield, Jr.5.1%Apr 3, 2026
ActivistBIBios Fund I, LP2.6%Feb 23, 2026
InsiderKWKreis Leslie W.Sell $44KJun 13, 2025
InsiderFGFletcher Aaron G.L.Sell $44KJun 13, 2025
InsiderFGFletcher Aaron G.L.Sell $38KJun 13, 2025
InsiderKWKreis Leslie W.Sell $38KJun 13, 2025
InsiderFGFletcher Aaron G.L.Sell $22KJun 13, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
332,079$454,9480.0%+32.84%
37
Increased
116,000(+5.1%)$158,9200.0%-33.32%
24
Increased
111,646(+15.4%)$152,9840.0%-64.62%
18
New
49,607$67,9620.0%+32.84%
32
Increased
45,267(+2.3%)$62,0160.0%+10.05%
15
Decreased
38,060(-2.7%)$52,1420.0%-10.11%
0
Decreased
27,399(-28.0%)$37,5420.0%-80.66%
0
Decreased
26,373(-4.4%)$36,1310.0%-21.88%
0
Unchanged
23,814$32,6250.0%-22.91%
0
Unchanged
23,652$32,4030.0%-15.89%
0
Decreased
21,301(-19.6%)$29,1820.0%-77.88%
0
Unchanged
15,589$21,3570.0%-76.48%
0
Decreased
15,432(-3.4%)$21,1420.0%+17.65%
0
Unchanged
12,228$16,7520.0%+17.65%
0
Decreased
10,077(-5.2%)$13,8050.0%-47.29%
0
New
2,355$3,2260.0%+32.84%
21
Unchanged
1,475$2,0210.0%-29.79%
0
Unchanged
601$8230.0%-22.87%
0
Unchanged
500$6850.0%+12.85%
0
New
500$6850.0%+32.84%
17

Showing 1-20 of 28

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used